🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher Rushton

Simon Fraser University

ORCID: 0000-0001-6306-9361

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma”.

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-020-0757-z

N/A

0.661DataRank · unranked

81 citations

Shannon Healy, Ali Bashashati, Saeed Saberi, Christoffer Hother, Anja Mottok +52 more

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Blood Advances(2021)10.1182/bloodadvances.2021004770

N/A

0.660DataRank · unranked

19 citations

Laura K. Hilton, Margaret Ashton‐Key, Chantal E. Hargreaves, Chern Siang Lee, Russell B. Foxall +23 more

Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.22.445261

N/A

0DataRank · unranked

3 citations

Jie Gao, Shannon Healy, Christopher Rushton, Nicole Thomas, Laura K. Hilton +14 more